ADGRF1 and metabolic dysfunction-associated steatotic liver disease: The argument mainly based on the findings that HFD-induced steatosis and liver injury were exacerbated in obese mice with high Adgrf1 overexpression level, and knockdown hepatic Adgrf1 alleviated the severity of obesity-induced NAFLD.